The effect of hymenoptera venom immunotherapy on neutrophils, interleukin 8 (IL-8) and interleukin 17 (IL-17).


Journal

International journal of occupational medicine and environmental health
ISSN: 1896-494X
Titre abrégé: Int J Occup Med Environ Health
Pays: Poland
ID NLM: 9437093

Informations de publication

Date de publication:
20 Oct 2020
Historique:
pubmed: 9 10 2020
medline: 2 4 2021
entrez: 8 10 2020
Statut: ppublish

Résumé

Venom immunotherapy (VIT) is an effective treatment method and is addressed to patients with a history of an anaphylactic reaction to Hymenoptera stings. However, the immunological mechanisms of protection have not been explained yet. The objective of this study was to analyze neutrophils, interleukin 8 (IL-8) and interleukin 17 (IL-17) before and after the initial phase of the immunotherapy. Overall, 40 individuals, including 20 wasp venom sensitized and 20 bee venom sensitized patients, were included in the study. The patients had had a history of severe allergic reactions type III and IV according to Mueller's classification. An ultra-rush VIT protocol was used in this study. The concentration of serum IL-8 and IL-17A was determined using the ELISA enzymatic method. The authors demonstrated a significant rise in the IL-8 level after the immunotherapy, compared to baseline (14.9 vs. 24.7, p < 0.05). The rise in the neutrophils level was also noticeable but proved to be barely out of the range of statistical significance (4.3 vs. 5.0, p = 0.06). The shift in IL-17A was negligent and not statistically significant in the paired samples t-test (1.6 vs. 1.5, p = 0.34). Venom immunotherapy induces neutrophils and IL-8 activity after 2 days. After the desensitization, the level of IL-17A did not change. Int J Occup Med Environ Health. 2020;33(6):811-7.

Identifiants

pubmed: 33029028
pii: 125132
doi: 10.13075/ijomeh.1896.01435
pii:
doi:

Substances chimiques

Arthropod Venoms 0
Interleukin-17 0
Interleukin-8 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

811-817

Informations de copyright

This work is available in Open Access model and licensed under a CC BY-NC 3.0 PL license.

Auteurs

Krzysztof Pałgan (K)

Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland (Department of Allergology, Clinical Immunology and Internal Diseases).

Magdalena Żbikowska-Gotz (M)

Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland (Department of Allergology, Clinical Immunology and Internal Diseases).

Robert Zacniewski (R)

Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland (Department of Allergology, Clinical Immunology and Internal Diseases).

Zbigniew Bartuzi (Z)

Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland (Department of Allergology, Clinical Immunology and Internal Diseases).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH